Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Lars Ekman currently holds 27,000 shares of Ultragenyx Pharmaceutical Inc. (RARE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Lars Ekman has been a net seller of RARE stock. They have purchased $72.0K and sold $15.1M worth of shares.
Lars Ekman's most recent insider trade was on May 15, 2026, when they sold 27,000 shares at $0.00 per share.
Lars Ekman serves as Executive at Ultragenyx Pharmaceutical Inc. (RARE). They have executed 66 insider transactions totaling $15.2M over their tenure at the company.
Lars Ekman holds the position of Executive at Ultragenyx Pharmaceutical Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 14 years and currently hold a stake valued at $0.
Lars Ekman has shown a selling trading pattern, with $72.0K in total purchases and $15.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Lars Ekman was on Mar 4, 2019, when they sold $2.1M worth of AMRN shares. This transaction involved 98,677 shares at $21.16 per share.
Lars Ekman currently owns 27,000 shares of Ultragenyx Pharmaceutical Inc. (RARE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Lars Ekman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Lars Ekman has 66 Form 4 filings on record as an insider at Ultragenyx Pharmaceutical Inc..
Set alerts for Lars Ekman and 40,000+ other insiders.